Ribostamycin is a broad-spectrum antimicrobial isolated fromStreptomyces ribosifidicus. It is used in pharmacokinetic and nephrotoxicity studies

For R&D use onlynot for drug household or other uses.

Ribostamycin is an aminoglycoside-aminocyclitol antibiotic isolated from a streptomycete Streptomyces ribosidificus originally identified in a soil sample from Tsu City of Mie Prefecture in Japan. It is made up of 3 ring subunits 2-deoxystreptamine (DOS) neosamine C and ribose. Ribostamycin along with other aminoglycosides with the DOS subunit is an important broad-spectrum antibiotic with important use against human immunodeficiency virus and is considered a critically important antimicrobial by the World Health Organization. Resistance against aminoglycoside antibiotics such as ribostamycin is a growing concern. The resistant bacteria contain enzymes that modify the structure through phosphorylation adenylation and acetylation and prevent the antibiotic from being able to interact with the bacterial ribosomal RNAs.